Senior Director, Global Value Access and Pricing, NSCLC

Role: Lead global value, access, and pricing strategy for Revolution Medicines' oncology assets, focusing on maximizing long-term asset value and patient access across the product lifecycle. Responsibilities include developing differentiated value propositions, influencing clinical development and lifecycle management, and ensuring alignment with payer and HTA requirements. The role involves partnering with cross-functional teams—Clinical Development, HEOR, Medical Affairs, Regulatory, and Commercial—to integrate market access considerations into development and commercialization plans. Requirements: Bachelor’s degree; 12+ years in market access, pricing, HEOR, or related biopharma functions, with global leadership experience. Deep expertise in oncology product pricing, reimbursement, and payer systems across major markets. Proven influence on clinical and commercial strategies, strong strategic and stakeholder management skills. Preferred: Experience in thoracic or biomarker-driven oncology, understanding of companion diagnostics, and familiarity with global healthcare policies. High-value: Oncology, late-stage clinical development, global market access, HTA strategies, and reimbursement frameworks. Work setup: Not specified; role likely based at headquarters with potential for regional coordination.